Are you healthy and looking to help advance medical science?

You may be eligible to participate in a anal cancer clinical study, and could be compensated for your time.

Are you healthy and looking to help advance medical science? You may be eligible to participate in a anal cancer clinical study, and could be compensated for your time.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Anal Cancer Clinical Trial
NCT02012699 | Observational patient registry

Are you healthy and looking to help advance medical science?

You may be eligible to participate in a anal cancer clinical study, and could be compensated for your time.

Are you healthy and looking to help advance medical science? You may be eligible to participate in a anal cancer clinical study, and could be compensated for your time.

Recruiting

Male & Female

19 - 110

Years old

This study is looking to recruit 999999 Participants

The iCaRe2 is a multi-institutional resource created and maintained by the Fred & Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, high-risk individuals, and normal controls. The distinct characteristic of the iCaRe2 is its geographical coverage, with a significant percentage of small and rural hospitals and cancer centers. The iCaRe2 advances comprehensive studies of risk factors of cancer development and progression and enables the design of novel strategies for prevention, screening, early detection and personalized treatment of cancer. Centers with expertise in cancer epidemiology, genetics, biology, early detection, and patient care can collaborate by using the iCaRe2 as a platform for cohort and population studies.